Search

everythinglearnresearchcommunity

for

Search:↓

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Scientists created keratinocyte cell lines from human hair that can differentiate similarly to normal skin cells, offering a new way to study skin biology and diseases.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

HIV patients with lower CD4 T cell counts often have more skin problems.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Timely treatment with antibiotics and antiretrovirals can significantly improve health in HIV patients with syphilis.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Dermal papilla cells from human hair follicles form unique structures and don't live as long as other skin cells in lab conditions.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.